Vericel Corp. (VCEL)
38.34
+0.47
(+1.24%)
USD |
NASDAQ |
Sep 11, 16:00
38.33
-0.01
(-0.03%)
After-Hours: 20:00
Vericel Price : 38.34 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 38.39 | 38.94 | 37.35 | 38.34 | 503531.0 |
| Sep 10, 2026 | 38.56 | 38.82 | 37.67 | 37.87 | 340237.0 |
| Sep 09, 2026 | 38.72 | 39.19 | 38.53 | 38.99 | 366515.0 |
| Sep 08, 2026 | 39.69 | 39.72 | 38.74 | 39.08 | 410295.0 |
| Sep 04, 2026 | 40.04 | 40.57 | 39.85 | 40.19 | 312915.0 |
| Sep 03, 2026 | 41.30 | 41.30 | 40.08 | 40.47 | 301274.0 |
| Sep 02, 2026 | 40.49 | 41.49 | 40.35 | 40.89 | 395530.0 |
| Sep 01, 2026 | 39.87 | 41.44 | 39.66 | 40.50 | 651114.0 |
| Aug 31, 2026 | 40.48 | 40.88 | 39.34 | 39.90 | 636305.0 |
| Aug 28, 2026 | 41.18 | 41.46 | 40.51 | 40.95 | 491248.0 |
| Aug 27, 2026 | 42.39 | 42.65 | 41.16 | 41.18 | 533522.0 |
| Aug 26, 2026 | 43.22 | 43.22 | 42.33 | 42.44 | 313606.0 |
| Aug 25, 2026 | 42.95 | 43.25 | 42.53 | 43.22 | 465743.0 |
| Aug 24, 2026 | 42.68 | 43.34 | 41.95 | 42.30 | 812271.0 |
| Aug 21, 2026 | 42.36 | 42.85 | 41.76 | 42.68 | 647128.0 |
| Aug 20, 2026 | 42.83 | 43.48 | 41.68 | 42.11 | 567686.0 |
| Aug 19, 2026 | 45.04 | 46.01 | 42.89 | 43.57 | 630188.0 |
| Aug 18, 2026 | 43.59 | 45.38 | 43.59 | 44.26 | 549697.0 |
| Aug 17, 2026 | 43.75 | 44.31 | 43.41 | 43.59 | 276261.0 |
| Aug 14, 2026 | 44.53 | 44.55 | 43.65 | 44.20 | 276054.0 |
| Aug 13, 2026 | 45.34 | 46.13 | 43.74 | 44.54 | 527894.0 |
| Aug 12, 2026 | 44.11 | 44.90 | 43.66 | 44.73 | 290767.0 |
| Aug 11, 2026 | 44.30 | 45.27 | 44.01 | 44.35 | 416861.0 |
| Aug 10, 2026 | 44.48 | 44.82 | 43.15 | 43.95 | 415810.0 |
| Aug 07, 2026 | 44.83 | 45.56 | 44.35 | 45.09 | 472912.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 257.12 |
| ADMA Biologics, Inc. | 9.23 |
| Kyntra Bio, Inc. | 7.97 |
| Conexeu Sciences, Inc. | 4.46 |
| ACADIA Pharmaceuticals, Inc. | 27.83 |
Price Related Metrics
| PE Ratio | 82.93 |
| PS Ratio | 6.480 |
| PEG Ratio | 0.306 |
| Price to Book Value | 5.302 |
| Price to Free Cash Flow | 32.19 |
| Earnings Yield | 1.21% |
| Market Cap | 1.962B |
| PEGY Ratio | 0.306 |
| Operating PE Ratio | 108.84 |
| Normalized PE Ratio | 82.95 |